Cargando…
Eosinophilia Is Associated with Improved COVID-19 Outcomes in Inhaled Corticosteroid-Treated Patients
BACKGROUND: In addition to their proinflammatory effect, eosinophils have antiviral properties. Similarly, inhaled corticosteroids (ICS) were found to suppress coronavirus replication in vitro and were associated with improved outcomes in coronavirus disease 2019 (COVID-19). However, the interplay b...
Autores principales: | Zein, Joe G., Strauss, Ronald, Attaway, Amy H., Hu, Bo, Milinovich, Alex, Jawhari, Nesreen, Chamat, Soulaima S., Ortega, Victor E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757367/ https://www.ncbi.nlm.nih.gov/pubmed/35033701 http://dx.doi.org/10.1016/j.jaip.2021.12.034 |
Ejemplares similares
-
Eosinophilia is Associated with Improved COVID-19 Outcomes in Patients Treated with Inhaled Corticosteroids
por: Strauss, Ronald, et al.
Publicado: (2022) -
Intranasal Corticosteroids Are Associated with Better Outcomes in Coronavirus Disease 2019
por: Strauss, Ronald, et al.
Publicado: (2021) -
Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter"
por: Strauss, Ronald, et al.
Publicado: (2022) -
Inhaled corticosteroids do not adversely impact outcomes in COVID-19 positive patients with COPD: An analysis of Cleveland Clinic’s COVID-19 registry
por: Sen, Payal, et al.
Publicado: (2021) -
Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
por: Oshagbemi, Olorunfemi A., et al.
Publicado: (2018)